PepJunkie Home of the Peptonauts
More

Peptide Atlas · Small molecule

Methylene blue (methylthioninium chloride)

Methylthioninium chloride (methylene blue) is the standard treatment for methemoglobinemia; in 185 cases treated over 24 years at a New York poison center, 98% improved, and adverse effects were reported in 4.9%.

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

    • established
      Claim: Methylthioninium chloride for methemoglobinemia: 185 poison-center cases, 98% improved standing
    • resolved

    Effectiveness and tolerability of methylthioninium chloride (methylene blue) for the treatment of methemoglobinemia: twenty-four years of experience at a single poison center.

    Rothenberg R, Biary R, Hoffman RS

    pmid 40062661

    • preclinical
      Claim: Methylene blue's mitochondrial electron-carrying action and neuroprotection in animal models standing
    • resolved

    From Mitochondrial Function to Neuroprotection-an Emerging Role for Methylene Blue.

    Tucker D, Lu Y, Zhang Q

    pmid 28840449

A claim's standing is its latest row in an append-only history; a tombstone names the later evidence and the reason. The Graveyard and the Resurrection Yard.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.